177 related articles for article (PubMed ID: 18680274)
1. Further studies on lead compounds containing the opioid pharmacophore Dmt-Tic.
Balboni G; Fiorini S; Baldisserotto A; Trapella C; Sasaki Y; Ambo A; Marczak ED; Lazarus LH; Salvadori S
J Med Chem; 2008 Aug; 51(16):5109-17. PubMed ID: 18680274
[TBL] [Abstract][Full Text] [Related]
2. Effect of lysine at C-terminus of the Dmt-Tic opioid pharmacophore.
Balboni G; Onnis V; Congiu C; Zotti M; Sasaki Y; Ambo A; Bryant SD; Jinsmaa Y; Lazarus LH; Trapella C; Salvadori S
J Med Chem; 2006 Sep; 49(18):5610-7. PubMed ID: 16942034
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the Dmt-Tic pharmacophore: conversion of a potent delta-opioid receptor antagonist into a potent delta agonist and ligands with mixed properties.
Balboni G; Guerrini R; Salvadori S; Bianchi C; Rizzi D; Bryant SD; Lazarus LH
J Med Chem; 2002 Jan; 45(3):713-20. PubMed ID: 11806723
[TBL] [Abstract][Full Text] [Related]
4. Potent delta-opioid receptor agonists containing the Dmt-Tic pharmacophore.
Balboni G; Salvadori S; Guerrini R; Negri L; Giannini E; Jinsmaa Y; Bryant SD; Lazarus LH
J Med Chem; 2002 Dec; 45(25):5556-63. PubMed ID: 12459023
[TBL] [Abstract][Full Text] [Related]
5. Direct influence of C-terminally substituted amino acids in the Dmt-Tic pharmacophore on delta-opioid receptor selectivity and antagonism.
Balboni G; Salvadori S; Guerrini R; Negri L; Giannini E; Bryant SD; Jinsmaa Y; Lazarus LH
J Med Chem; 2004 Jul; 47(16):4066-71. PubMed ID: 15267245
[TBL] [Abstract][Full Text] [Related]
6. Further studies on the Dmt-Tic pharmacophore: hydrophobic substituents at the C-terminus endow delta antagonists to manifest mu agonism or mu antagonism.
Salvadori S; Guerrini R; Balboni G; Bianchi C; Bryant SD; Cooper PS; Lazarus LH
J Med Chem; 1999 Dec; 42(24):5010-9. PubMed ID: 10585210
[TBL] [Abstract][Full Text] [Related]
7. N-terminal guanidinylation of TIPP (Tyr-Tic-Phe-Phe) peptides results in major changes of the opioid activity profile.
Weltrowska G; Nguyen TM; Chung NN; Wilkes BC; Schiller PW
Bioorg Med Chem Lett; 2013 Sep; 23(18):5082-5. PubMed ID: 23932788
[TBL] [Abstract][Full Text] [Related]
8. Bioactivity of new mu and delta opioid peptides.
Capasso A
Med Chem; 2007 Sep; 3(5):480-7. PubMed ID: 17897075
[TBL] [Abstract][Full Text] [Related]
9. Delta opioidmimetic antagonists: prototypes for designing a new generation of ultraselective opioid peptides.
Salvadori S; Attila M; Balboni G; Bianchi C; Bryant SD; Crescenzi O; Guerrini R; Picone D; Tancredi T; Temussi PA
Mol Med; 1995 Sep; 1(6):678-89. PubMed ID: 8529134
[TBL] [Abstract][Full Text] [Related]
10. Role of benzimidazole (Bid) in the delta-opioid agonist pseudopeptide H-Dmt-Tic-NH-CH(2)-Bid (UFP-502).
Salvadori S; Fiorini S; Trapella C; Porreca F; Davis P; Sasaki Y; Ambo A; Marczak ED; Lazarus LH; Balboni G
Bioorg Med Chem; 2008 Mar; 16(6):3032-8. PubMed ID: 18178091
[TBL] [Abstract][Full Text] [Related]
11. Crystal structures of dipeptides containing the Dmt-Tic pharmacophore.
Bryant SD; George C; Flippen-Anderson JL; Deschamps JR; Salvadori S; Balboni G; Guerrini R; Lazarus LH
J Med Chem; 2002 Dec; 45(25):5506-13. PubMed ID: 12459018
[TBL] [Abstract][Full Text] [Related]
12. Evolution of the Dmt-Tic pharmacophore: N-terminal methylated derivatives with extraordinary delta opioid antagonist activity.
Salvadori S; Balboni G; Guerrini R; Tomatis R; Bianchi C; Bryant SD; Cooper PS; Lazarus LH
J Med Chem; 1997 Sep; 40(19):3100-8. PubMed ID: 9301674
[TBL] [Abstract][Full Text] [Related]
13. New 2',6'-dimethyl-L-tyrosine (Dmt) opioid peptidomimetics based on the Aba-Gly scaffold. Development of unique mu-opioid receptor ligands.
Ballet S; Salvadori S; Trapella C; Bryant SD; Jinsmaa Y; Lazarus LH; Negri L; Giannini E; Lattanzi R; Tourwé D; Balboni G
J Med Chem; 2006 Jun; 49(13):3990-3. PubMed ID: 16789756
[TBL] [Abstract][Full Text] [Related]
14. Further studies on the effect of lysine at the C-terminus of the Dmt-Tic opioid pharmacophore.
Balboni G; Onnis V; Congiu C; Zotti M; Sasaki Y; Ambo A; Bryant SD; Jinsmaa Y; Lazarus LH; Lazzari I; Trapella C; Salvadori S
Bioorg Med Chem; 2007 May; 15(9):3143-51. PubMed ID: 17339114
[TBL] [Abstract][Full Text] [Related]
15. Assessment of substitution in the second pharmacophore of Dmt-Tic analogues.
Santagada V; Balboni G; Caliendo G; Guerrini R; Salvadori S; Bianchi C; Bryant SD; Lazarus LH
Bioorg Med Chem Lett; 2000 Dec; 10(24):2745-8. PubMed ID: 11133082
[TBL] [Abstract][Full Text] [Related]
16. Conversion of the potent delta-opioid agonist H-Dmt-Tic-NH-CH(2)-bid into delta-opioid antagonists by N(1)-benzimidazole alkylation(1).
Balboni G; Guerrini R; Salvadori S; Negri L; Giannini E; Bryant SD; Jinsmaa Y; Lazarus LH
J Med Chem; 2005 Dec; 48(26):8112-4. PubMed ID: 16366592
[TBL] [Abstract][Full Text] [Related]
17. Role of 2',6'-dimethyl-l-tyrosine (Dmt) in some opioid lead compounds.
Balboni G; Marzola E; Sasaki Y; Ambo A; Marczak ED; Lazarus LH; Salvadori S
Bioorg Med Chem; 2010 Aug; 18(16):6024-30. PubMed ID: 20637637
[TBL] [Abstract][Full Text] [Related]
18. Potent Dmt-Tic pharmacophoric delta- and mu-opioid receptor antagonists.
Li T; Fujita Y; Shiotani K; Miyazaki A; Tsuda Y; Ambo A; Sasaki Y; Jinsmaa Y; Marczak E; Bryant SD; Salvadori S; Lazarus LH; Okada Y
J Med Chem; 2005 Dec; 48(25):8035-44. PubMed ID: 16335927
[TBL] [Abstract][Full Text] [Related]
19. Anxiolytic- and antidepressant-like activities of H-Dmt-Tic-NH-CH(CH2-COOH)-Bid (UFP-512), a novel selective delta opioid receptor agonist.
Vergura R; Balboni G; Spagnolo B; Gavioli E; Lambert DG; McDonald J; Trapella C; Lazarus LH; Regoli D; Guerrini R; Salvadori S; Caló G
Peptides; 2008 Jan; 29(1):93-103. PubMed ID: 18069089
[TBL] [Abstract][Full Text] [Related]
20. Dmt-Tic-NH-CH2-Bid (UFP-502), a potent DOP receptor agonist: in vitro and in vivo studies.
Vergura R; Valenti E; Hebbes CP; Gavioli EC; Spagnolo B; McDonald J; Lambert DG; Balboni G; Salvadori S; Regoli D; Calo' G
Peptides; 2006 Dec; 27(12):3322-30. PubMed ID: 16963157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
